305381-05-9 Usage
Uses
Used in Pharmaceutical Industry:
4-Pyridinecarbonitrile,2-(1-piperazinyl)-(9CI) is used as a pharmaceutical intermediate for the development of drugs targeting serotonin and dopamine receptors. Its antagonistic properties make it a promising candidate for the treatment of various neurological and psychiatric disorders.
Used in Medicinal Chemistry Research:
4-Pyridinecarbonitrile,2-(1-piperazinyl)-(9CI) is used as a research compound in medicinal chemistry to explore its potential as an antipsychotic and antidepressant agent. Its unique structure and receptor binding properties allow researchers to investigate its therapeutic potential and optimize its pharmacological profile.
Used in Organic Synthesis:
4-Pyridinecarbonitrile,2-(1-piperazinyl)-(9CI) is used as a building block in organic synthesis for the preparation of various chemical compounds. Its versatile structure allows for the synthesis of a wide range of molecules with potential applications in different industries, including pharmaceuticals, agrochemicals, and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 305381-05-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,5,3,8 and 1 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 305381-05:
(8*3)+(7*0)+(6*5)+(5*3)+(4*8)+(3*1)+(2*0)+(1*5)=109
109 % 10 = 9
So 305381-05-9 is a valid CAS Registry Number.
305381-05-9Relevant academic research and scientific papers
Compounds for the treatment of obesity
-
Page column 72, (2008/06/13)
NPY antagonists, methods of using such NPY antagonists and pharmaceutical compositions containing such NPY antagonists. The NPY antagonists are useful for the treatment of NPY mediated disease/conditions including obesity.
Compounds for the treatment of obesity
-
, (2008/06/13)
NPY antagonists, methods of using such NPY antagonists and pharmaceutical compositions containing such NPY antagonists. The NPY antagonists are useful for the treatment of NPY mediated disease/conditions including obesity.
